Growth Metrics

Cytosorbents (CTSO) Free Cash Flow Growth (3y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Growth (3y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 6.28%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 9.63%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 22.80%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 29.36%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -27.72%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -0.27%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 77.20%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -20.37%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 19.32%
10 Cytosorbents 28.81 Mn 24.01 Mn 6.13 Mn 27.73%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 27.73%
Dec 31, 2025 23.79%
Sep 30, 2025 -13.35%
Jun 30, 2025 48.22%
Mar 31, 2025 30.33%
Dec 31, 2024 35.86%
Sep 30, 2024 3.57%
Jun 30, 2024 -19.43%
Mar 31, 2024 -20.69%
Dec 31, 2023 -74.69%
Sep 30, 2023 -15.03%
Jun 30, 2023 -80.64%
Mar 31, 2023 3.37%
Dec 31, 2022 -37.75%
Sep 30, 2022 30.62%
Jun 30, 2022 -49.59%
Mar 31, 2022 -31.30%
Dec 31, 2021 -46.86%
Sep 30, 2021 -3.08%
Jun 30, 2021 7.06%
Mar 31, 2021 -4.26%
Dec 31, 2020 -14.14%
Sep 30, 2020 -11.52%
Jun 30, 2020 42.76%
Mar 31, 2020 -18.78%
Dec 31, 2019 -58.85%
Sep 30, 2019 -28.30%
Jun 30, 2019 -18.79%
Mar 31, 2019 -51.73%
Dec 31, 2018 -7.32%
Sep 30, 2018 -4.00%
Jun 30, 2018 -9.40%
Mar 31, 2018 -5.83%
Dec 31, 2017 27.54%
Sep 30, 2017 -8.88%
Jun 30, 2017 -10.98%
Mar 31, 2017 -35.76%
Dec 31, 2016 1.34%
Sep 30, 2016 -64.80%
Jun 30, 2016 -23.88%
Mar 31, 2016 -16.91%
Dec 31, 2015 -43.97%
Sep 30, 2015 -55.08%
Jun 30, 2015 -32.83%
Mar 31, 2015 -24.40%
Dec 31, 2014 -24.78%
Sep 30, 2014 -20.71%
Jun 30, 2014 -13.10%
Mar 31, 2014 -11.79%
Dec 31, 2013 -18.36%
Sep 30, 2013 3.83%